Y. Nakazawa et al., Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection, HEPATOLOGY, 32(6), 2000, pp. 1240-1247
Fibrosis in liver allografts undergoing chronic rejection (CR) is variable
and poorly understood. The temporal and spatial relationships of venous, ar
terial, and biliary lesions were studied to clarify their potential contrib
utions to graft fibrosis. The severity, prevalence, and morphology of intim
al lesions of vessels were analyzed and compared with the fibrosis stage. T
hree groups were found; group 1 (n = 5) with no hepatic vein (HV) lesions,
group 2 (n = 5) with HV lesions only, and group 3 with lesions of both HV a
nd portal veins (PV), The earliest lesion to develop, in 71% of grafts, was
concentric intimal thickening of small HV, This was significantly more sev
ere and frequent in grafts from group 3. With increasing frequency and seve
rity of small HV sclerosis, fibrosis developed in medium/large veins. The m
orphology of larger vessel lesions suggested organized thrombus. Centrilobu
lar fibrosis was significantly more severe in group 3 and developed unpredi
ctably and sometimes rapidly. Conversely, portal fibrosis scores were signi
ficantly higher in grafts with ductular proliferation and did not correlate
with venous lesions. This suggests that in CR, venoocclusive-like lesions
develop commonly in terminal hepatic venules, probably caused by immune-med
iated damage. In only a proportion, with increased frequency and severity o
f the lesions, stasis and thrombosis in portal and larger veins occur and c
ould result in loss of hepatic and portal venous outflow, which leads to is
chemia and fibrosis. The stage of fibrosis did not correlate with foam-cell
arteriopathy, A second pathway of portal fibrosis occurs in patients with
longstanding biliary proliferation.